Back
Apellis Pharmaceuticals, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
56
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$25.23
Seasonality Move:
7.92%
Sell
26
NVO
Novo Nordisk A/S
Last Price:
$50.17
Seasonality Move:
3.09%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.23. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $50.18. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $25.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $50.18The current trend is relatively stagnant and NVO is experiencing slight selling pressure.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 68.46 | Buy |
| Chaikin Money Flow: | 1409326 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.36 - 23.18) | Buy |
| Bollinger Bands (100): | (20.82 - 26.96) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 54.9 | Buy |
| Chaikin Money Flow: | -4526726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.65 - 49.41) | Buy |
| Bollinger Bands (100): | (47.99 - 58.53) | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.69 | Buy |
| 20-day SMA: | 21.71 | Buy |
| 50-day SMA: | 23.11 | Buy |
| 200-day SMA: | 21.92 | Buy |
| 8-day EMA: | 23.84 | Buy |
| 20-day EMA: | 22.66 | Buy |
| 50-day EMA: | 22.73 | Buy |
| 200-day EMA: | 24.25 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.26 | Buy |
| 20-day SMA: | 48.03 | Buy |
| 50-day SMA: | 51.08 | Sell |
| 200-day SMA: | 61.89 | Sell |
| 8-day EMA: | 48.72 | Buy |
| 20-day EMA: | 48.57 | Buy |
| 50-day EMA: | 50.6 | Sell |
| 200-day EMA: | 63.84 | Sell |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and a decrease next year of $0.15 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||